company had good news from trial. Yet, the no press release only a 8k ( required ) my guess they entered into talks, agreed to a quiet period, had some good news meant SEC requirements but left it at that.
the key is the new data. big pharma just got the data they need to acquire sgyp for $18+. everyone was waiting for the data. we now have it. SGYP's Plecanatide is just as good or better than IRWD's Linzess. Linzess drug is worth $4.5 bil vs $450 mil for SGYP. SGYP should already be a $12-$15 stock. I think we will get there quick
I've been with this stock (and callisto) a long time, probably longer than anyone on this board. I can tell you for a fact that they've been "in talks" for years...and years. It's just a matter of finding the right time and the right acquirer to say "I do." So, we can stop speculating on whether or not they are in talks. They are. They pretty much always have been.